The development of deep learning models and techniques to harness the potential of data mining in biological sequences with limited data availability is a vital need. This necessity arises from unique biological characteristics and technical constraints that limit access to sufficient quantities of high-quality data across many biological and genetic fields. Building on a data augmentation strategy that generates overlapping augmented subsequences, an aggregated CNN-LSTM-Attention-Residual architecture was developed for analysis at the original full-length sequence level. The model was independently tested and validated on three sets of regulatory sequences from evolutionarily diverse organisms, chloroplasts sharing a common ancestor, and prokaryotic sequences, comprising 100, 50, and 100 sequences per group, respectively, within each dataset. Trained on augmented subsequences, the model effectively aggregated and transferred high-level features back to the original full-length sequences. It achieved high performance with approximately 96% accuracy, recall, precision, F1-score, and AUC at the subsequence level. The model correctly distinguished the sequences of the distinct groups at the full-length sequence level across all datasets. The strong performance confirmed that an ensemble of features learned from short, overlapping subsequences provide an informative signature for classifying full-length regulatory regions. The combination of first-level training on augmented subsequences with dual-level validation—evaluating both subsequences and their corresponding full-length sequences— provides a framework for advance model development in limited-data biological sequence analysis.
No takes yet. Share an insight, caveat, or question.
Abbasi-Vineh et al. (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: